Estimating screening-level organic chemical half-lives in humans.

Relatively few measured data are available for the thousands of chemicals requiring hazard and risk assessment. The whole body, total elimination half-life (HLT) and the whole body, primary biotransformation half-life (HLB) are key parameters determining the extent of bioaccumulation, biological concentration, and risk from chemical exposure. A one-compartment pharmacokinetic (1-CoPK) mass balance model was developed to estimate organic chemical HLB from measured HLT data in mammals. Approximately 1900 HLs for human adults were collected and reviewed and the 1-CoPK model was parametrized for an adult human to calculate HLB from HLT. Measured renal clearance and whole body total clearance data for 306 chemicals were used to calculate empirical HLB,emp. The HLB,emp values and other measured data were used to corroborate the 1-CoPK HLB model calculations. HLs span approximately 7.5 orders of magnitude from 0.05 h for nitroglycerin to 2 × 10(6) h for 2,3,4,5,2',3',5',6'-octachlorobiphenyl with a median of 7.6 h. The automated Iterative Fragment Selection (IFS) method was applied to develop and evaluate various quantitative structure-activity relationships (QSARs) to predict HLT and HLB from chemical structure and two novel QSARs are detailed. The HLT and HLB QSARs show similar statistical performance; that is, r(2) = 0.89, r(2-ext) = 0.72 and 0.73 for training and external validation sets, respectively, and root-mean-square errors for the validation data sets are 0.70 and 0.75, respectively.

[1]  Franco Lombardo,et al.  Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds , 2008, Drug Metabolism and Disposition.

[2]  Jon A Arnot,et al.  A quantitative structure‐activity relationship for predicting metabolic biotransformation rates for organic chemicals in fish , 2009, Environmental toxicology and chemistry.

[3]  Michael S. McLachlan,et al.  Prioritizing Chemicals and Data Requirements for Screening-Level Exposure and Risk Assessment , 2012, Environmental health perspectives.

[4]  Michael S McLachlan,et al.  Bioaccumulation potential of persistent organic chemicals in humans. , 2004, Environmental science & technology.

[5]  Jon A Arnot,et al.  Estimating metabolic biotransformation rates in fish from laboratory data , 2008, Environmental toxicology and chemistry.

[6]  J F Brown,et al.  Determination of PCB Metabolic, Excretion, and Accumulation Rates for Use as Indicators of Biological Response and Relative Risk. , 1994, Environmental science & technology.

[7]  Jon A Arnot,et al.  A database of fish biotransformation rates for organic chemicals , 2008, Environmental toxicology and chemistry.

[8]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[9]  James Vail,et al.  The exposure data landscape for manufactured chemicals. , 2012, The Science of the total environment.

[10]  M. Jamei,et al.  PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. , 2010, Toxicology.

[11]  Walter Schmitt,et al.  General approach for the calculation of tissue to plasma partition coefficients. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  M. Huijbregts,et al.  Bioaccumulation potential of air contaminants: combining biological allometry, chemical equilibrium and mass-balances to predict accumulation of air pollutants in various mammals. , 2009, Toxicology and applied pharmacology.

[13]  F. Gobas,et al.  Quantitative Structure Activity Relationships for Predicting the Bioaccumulation of POPs in Terrestrial Food‐Webs , 2003 .

[14]  Melvin E Andersen,et al.  Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  O. Jolliet,et al.  Apparent Half-Lives of Dioxins, Furans, and Polychlorinated Biphenyls as a Function of Age, Body Fat, Smoking Status, and Breast-Feeding , 2008, Environmental health perspectives.

[16]  Jon A Arnot,et al.  Bioaccumulation of organic contaminants in humans: a multimedia perspective and the importance of biotransformation. , 2011, Environmental science & technology.

[17]  F. Gobas,et al.  Food Web–Specific Biomagnification of Persistent Organic Pollutants , 2007, Science.

[18]  Satoshi Endo,et al.  Elimination half‐life as a metric for the bioaccumulation potential of chemicals in aquatic and terrestrial food chains , 2013, Environmental toxicology and chemistry.

[19]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[20]  Arnaud Tonnelier,et al.  Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model , 2011, Archives of Toxicology.

[21]  Paola Gramatica,et al.  The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .

[22]  Robert J Kavlock,et al.  Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Jon A Arnot,et al.  Development and evaluation of a mechanistic bioconcentration model for ionogenic organic chemicals in fish , 2013, Environmental toxicology and chemistry.

[24]  Mohamed Abou-Elwafa Abdallah,et al.  Indoor contamination with hexabromocyclododecanes, polybrominated diphenyl ethers, and perfluoroalkyl compounds: an important exposure pathway for people? , 2010, Environmental science & technology.

[25]  A. Calafat,et al.  Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000 , 2007, Environmental health perspectives.

[26]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[27]  G R Wilkinson,et al.  Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. , 1977, The Journal of pharmacology and experimental therapeutics.

[28]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[29]  C. Hansch.  Quantitative Relationships Between Lipophilic Character and Drug Metabolism , 1972 .

[30]  K. Hungerbühler,et al.  Intrinsic Human Elimination Half-Lives of Polychlorinated Biphenyls Derived from the Temporal Evolution of Cross-Sectional Biomonitoring Data from the United Kingdom , 2010, Environmental health perspectives.

[31]  Jon A Arnot,et al.  Iterative fragment selection: a group contribution approach to predicting fish biotransformation half-lives. , 2012, Environmental science & technology.

[32]  Sean Ekins,et al.  Computational prediction of human drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.

[33]  F. Gobas,et al.  A terrestrial food-chain bioaccumulation model for POPs. , 2007, Environmental science & technology.

[34]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[35]  P. Howard,et al.  Are there other persistent organic pollutants? A challenge for environmental chemists. , 2006, Environmental science & technology.

[36]  Thomas F Parkerton,et al.  Multimedia modeling of human exposure to chemical substances: The roles of food web biomagnification and biotransformation , 2010, Environmental toxicology and chemistry.

[37]  R. Obach,et al.  Physicochemical determinants of human renal clearance. , 2009, Journal of medicinal chemistry.

[38]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.